News
BioNTech (NASDAQ:BNTX – Get Free Report) had its target price dropped by analysts at HC Wainwright from $150.00 to $145.00 in ...
We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...
In the latest quarter, 6 analysts provided ratings for BioNTech (NASDAQ:BNTX), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...
BioNTech SE (NASDAQ:BNTX – Free Report) – Research analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of BioNTech in a note issued to investors on Tuesday ...
BioNTech SE (NASDAQ:BNTX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eighteen brokerages that are covering the company, MarketBeat.com reports. Three research ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of BioNTech SE (Symbol: BNTX) entered into oversold territory, hitting an RSI reading of 29.3 ...
Below is Validea's guru fundamental report for BIONTECH SE - ADR (BNTX). Of the 22 guru strategies we follow, BNTX rates highest using our Value Investor model based on the published strategy of ...
Vaccine stocks have been under significant pressure in recent days following news that the FDA director who oversaw the ...
Mitsubishi UFJ Asset Management Co. Ltd. reduced its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 20.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results